| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ti |
| Brand: | Abnova |
| Reference: | PAB6217 |
| Product name: | ARL4A polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of ARL4A. |
| Gene id: | 10124 |
| Gene name: | ARL4A |
| Gene alias: | ARL4 |
| Gene description: | ADP-ribosylation factor-like 4A |
| Immunogen: | A synthetic peptide corresponding to human ARL4A. |
| Immunogen sequence/protein sequence: | GNGLSDQTSILSN-C |
| Protein accession: | NP_005729 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:1000) Western blot (1-3 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Specificity: | This antibody is also expected to react with a hypothetical human protein, XP_166703, and a hypothetical mouse protein, AAH03725 - both very similar to ARL4. |
| Reactivity: | Human |
| Application image: | ![]() |
| Application image note: | ARL4A polyclonal antibody (Cat # PAB6217) staining (2 ug/mL) of human testis lysate (RIPA buffer, 30 ug total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence. |
| Applications: | ELISA,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | The mouse ADP-ribosylation factor-like 4 gene: two separate promoters direct specific transcription in tissues and testicular germ cell.Jacobs S, Schurmann A, Becker W, Bockers TM, Copeland NG, Jenkins NA, Joost HG. Biochem J. 1998 Oct 15;335 ( Pt 2):259-65. |